Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FZG22
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,327
Award facts
- Contract value 100% obligated
- $33,326.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $33,326.88 by the Defense Logistics Agency (DLA) on July 28, 2025. The contract, which carries no set-aside designation, covers the supply of Nexplanon 68 mg implants with an ultimate completion date of August 18, 2025. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products to support military healthcare facilities worldwide.
The Nexplanon implant delivery fulfills DLA's ongoing need to supply contraceptive devices and other specialized pharmaceutical products to Department of Defense healthcare sites. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts for branded and generic prescription drugs, biologics, and medical consumables across military and federal healthcare systems. The firm fixed-price structure of this delivery order ensures cost certainty for the government while leveraging DMS Pharmaceutical Group's position as an established federal pharmaceutical distributor with SAM.gov registration since 2001.
Quick answers
Who was awarded contract SPE2DB25FZG22?
SPE2DB25FZG22 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 28, 2025.
How much is contract SPE2DB25FZG22 worth?
The government has obligated $33,327 on SPE2DB25FZG22.
Is contract SPE2DB25FZG22 an order under another contract?
Yes. SPE2DB25FZG22 is a delivery order under SPE2DB22D9205, an indefinite delivery contract.
Was contract SPE2DB25FZG22 competed?
The extent of competition for SPE2DB25FZG22 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award